While our focus was on breast cancer, LURAP1L-AS1 has previously been implicated in the LURAP1L/IKK/IκB/NF-κB signaling pathway in other cancers, such as oral squamous cell carcinoma (OSCC) [19]. Here, NFKB1 is linked to breast cancer.